financetom
Business
financetom
/
Business
/
Clover Health Stock Surges Over 29% On High Volume: Recap
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Clover Health Stock Surges Over 29% On High Volume: Recap
Oct 2, 2024 9:38 PM

Clover Health Investments, Corp. ( CLOV ) shares are trading higher Wednesday amid increased trading volume and gaining traction across social media platforms.

Here’s what you need to know.

Counterpart Health Agreement with The Iowa Clinic: Last month, Clover Health’s subsidiary, Counterpart Health, announced a multi-year agreement with The Iowa Clinic. Clinicians serving The Iowa Clinic's Medicare Advantage and Medicare Shared Savings Program patients will utilize Counterpart Assistant, an AI-driven solution designed to integrate into physicians' workflows and facilitate the early diagnosis and management of chronic diseases.

The technology will also be available to The Iowa Clinic's clinically integrated network partners throughout the Midwest. Counterpart Health will receive a per-member, per-month fee and possible incentive payments tied to meeting specific care management objectives.

Ben Vallier, CEO of The Iowa Clinic, praised Counterpart's ability to harness clinical data for improved outcomes and its intuitive design tailored to clinicians’ needs.

Appointment of New COO: Clover Health also announced Joseph Brand as the new chief operating officer for its Medicare Advantage operations. Brand brings nearly 20 years of healthcare leadership experience, most recently serving as COO at Jefferson Health Plans. His focus will be on improving health care delivery in New Jersey through operational efficiencies and technological innovation.

What Else: Clover Health’s short interest has decreased by 9.75% since the last report, with 29.36 million shares shorted, representing 7.31% of the float. Traders on social media platforms, particularly Reddit's r/WallStreetBets, have been actively discussing Clover Health.

CLOV Price Action: Clover Health shares were up by 29.14% at $3.59 at publication Wednesday, according to Benzinga Pro.

See Also:

Are You Richer Than Your Friends? Here’s How To Tell Without Asking

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Evolus Submits Final Premarket Application for Facial Filler to FDA
Evolus Submits Final Premarket Application for Facial Filler to FDA
Aug 20, 2025
08:34 AM EDT, 08/20/2025 (MT Newswires) -- Evolus ( EOLS ) said Wednesday that it has completed its premarket approval application to the US Food and Drug Administration for Evolysse Sculpt, an injectable gel designed to restore volume in the mid-face. The company said it expects the FDA to follow its standard review process, with potential approval in the second...
ZJK Industrial Integrates Six-Flap Chuck Into Manufacturing Line
ZJK Industrial Integrates Six-Flap Chuck Into Manufacturing Line
Aug 20, 2025
08:36 AM EDT, 08/20/2025 (MT Newswires) -- ZJK Industrial ( ZJK ) said Wednesday that it has integrated a six-flap chuck into its manufacturing line to enhance efficiency and lower the risk of workpiece deformation. The chuck has been patented by the China National Intellectual Property Administration for a 10-year period, which adapts to the geometric center of a workpiece,...
Axcelis, GE Aerospace to Develop High Voltage Superjunction Power Devices
Axcelis, GE Aerospace to Develop High Voltage Superjunction Power Devices
Aug 20, 2025
08:36 AM EDT, 08/20/2025 (MT Newswires) -- Axcelis Technologies ( ACLS ) said Wednesday it has entered a joint program with GE Aerospace (GE) to develop production-worthy 6.5 to 10kV superjunction power devices. Under the deal, processes will be built on Purion high-energy ion implanters to support GE's high-voltage silicon carbide switches project, the company said. Shares of Axcelis (...
Guess agrees to $1.4 billion take-private deal
Guess agrees to $1.4 billion take-private deal
Aug 20, 2025
Aug 20 (Reuters) - Designer fashion brand Guess on Wednesday agreed to be taken private in a deal valued at $1.4 billion. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved